X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1744) 1744
Book Review (238) 238
Publication (80) 80
Newsletter (61) 61
Conference Proceeding (6) 6
Book Chapter (5) 5
Magazine Article (2) 2
Web Resource (2) 2
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1342) 1342
humans (951) 951
sulfasalazine (893) 893
sulfasalazine - pharmacology (593) 593
male (566) 566
pharmacology & pharmacy (526) 526
animals (519) 519
female (413) 413
sulfasalazine - therapeutic use (336) 336
adult (274) 274
rats (259) 259
mesalamine (213) 213
middle aged (210) 210
colitis, ulcerative - drug therapy (200) 200
ulcerative-colitis (190) 190
mice (187) 187
abridged index medicus (181) 181
5-aminosalicylic acid (168) 168
gastroenterology & hepatology (159) 159
arthritis, rheumatoid - drug therapy (157) 157
rheumatoid arthritis (150) 150
ulcerative colitis (146) 146
anti-inflammatory agents, non-steroidal - pharmacology (140) 140
anti-inflammatory agents, non-steroidal - therapeutic use (139) 139
inflammatory-bowel-disease (136) 136
methotrexate (132) 132
inflammatory bowel disease (131) 131
dose-response relationship, drug (128) 128
aged (122) 122
sulphasalazine (119) 119
aminosalicylic acids - pharmacology (117) 117
sulfasalazine - adverse effects (116) 116
drug therapy (108) 108
sulfasalazine - metabolism (106) 106
research (101) 101
rheumatology (100) 100
inhibition (99) 99
crohns-disease (98) 98
sulfasalazine - administration & dosage (98) 98
rheumatoid-arthritis (94) 94
therapy (94) 94
double-blind (93) 93
antirheumatic agents - therapeutic use (91) 91
expression (91) 91
inflammation (89) 89
analysis (88) 88
medicine & public health (87) 87
colitis (86) 86
time factors (86) 86
treatment outcome (86) 86
administration, oral (85) 85
drugs (84) 84
inflammatory bowel diseases - drug therapy (83) 83
pharmacology/toxicology (82) 82
sulfasalazine - pharmacokinetics (82) 82
disease models, animal (81) 81
toxicology (80) 80
immunology (79) 79
cells, cultured (78) 78
nf-kappa b - metabolism (78) 78
sulfasalazine, adverse reactions - serious (78) 78
adolescent (77) 77
colon - metabolism (77) 77
sulfapyridine - pharmacology (73) 73
colon - drug effects (72) 72
crohn disease - drug therapy (72) 72
drug therapy, combination (72) 72
rats, sprague-dawley (72) 72
rats, wistar (72) 72
sulfasalazine, adverse reactions (69) 69
in vitro techniques (68) 68
drug interactions (66) 66
risk factors (66) 66
aminosalicylic acids - therapeutic use (65) 65
inflammatory bowel-disease (65) 65
kinetics (65) 65
chemistry, medicinal (64) 64
metabolism (62) 62
colitis - drug therapy (61) 61
mesalazine (61) 61
pharmacology (61) 61
arthritis (60) 60
colon - pathology (60) 60
metabolites (60) 60
antirheumatic agents - pharmacology (59) 59
mesalamine - pharmacology (59) 59
oncology (59) 59
oxidative stress (59) 59
care and treatment (58) 58
methotrexate - therapeutic use (58) 58
anti-inflammatory agents, non-steroidal - adverse effects (57) 57
cell line, tumor (57) 57
mesalamine - therapeutic use (57) 57
pharmacokinetics (57) 57
pregnancy (57) 57
activation (56) 56
anti-inflammatory agents, non-steroidal - administration & dosage (56) 56
biochemistry & molecular biology (55) 55
cancer (55) 55
cell biology (55) 55
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1754) 1754
Japanese (18) 18
French (14) 14
German (12) 12
Chinese (6) 6
Russian (4) 4
Italian (2) 2
Dutch (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 03/1998, Volume 101, Issue 5, pp. 1163 - 1174
Transcription factors of the NF-kappa B/Rel family are critical for inducible expression of multiple genes involved in inflammatory responses, Sulfasalazine... 
Inflammatory bowel disease | NF-κB | Therapy | SW620 | AP1 | RHEUMATOID-ARTHRITIS | MEDICINE, RESEARCH & EXPERIMENTAL | TRANSCRIPTIONAL ACTIVATION | METABOLITES | PHOSPHORYLATION | therapy | ULCERATIVE-COLITIS | ACTIVE MOIETY | ALPHA | CELL-LINES | 5-AMINOSALICYLIC ACID | inflammatory bowel disease | NF-kappa B | SODIUM-SALICYLATE | Phosphorylation | Anti-Infective Agents - pharmacology | Humans | Tumor Necrosis Factor-alpha - genetics | NF-kappa B - metabolism | Sulfasalazine - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Cystine - pharmacology | Thiocarbamates - pharmacology | Transfection | Recombination, Genetic | Phorbol Esters - pharmacology | Proline - pharmacology | Colonic Diseases - drug therapy | Aspirin - pharmacology | Cystine - analogs & derivatives | Fluorescent Antibody Technique, Indirect | NF-kappa B - antagonists & inhibitors | Proline - analogs & derivatives | Anti-Inflammatory Agents - pharmacology | Cells, Cultured | Epithelial Cells | Antioxidants - pharmacology | Recombinant Proteins - pharmacology | Blotting, Western | Sulfapyridine - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Colonic Diseases - immunology | Immunosuppression | Mesalamine - pharmacology | Transcription Factor AP-1 - antagonists & inhibitors | NF-kappa B - genetics | Plasmids | Lipopolysaccharides - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Phytomedicine, ISSN 0944-7113, 02/2014, Volume 21, Issue 3, pp. 240 - 246
Coumarins, also known as benzopyrones, are plant-derived products with several pharmacological properties, including antioxidant and anti-inflammatory... 
Inflammatory bowel disease | Antioxidant | Coumarin derivatives | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | 4-METHYLESCULETIN | INDUCTION | PLANT SCIENCES | TRINITROBENZENESULFONIC ACID MODEL | ESCULETIN | INFLAMMATORY-BOWEL-DISEASE | METABOLISM | GLUTATHIONE | INTEGRATIVE & COMPLEMENTARY MEDICINE | RAT COLITIS | SULFASALAZINE | PHARMACOLOGY & PHARMACY | Rats, Wistar | Glutathione - metabolism | Plant Extracts - pharmacology | Alkaline Phosphatase - metabolism | Colon - drug effects | Male | Esculin - therapeutic use | Biphenyl Compounds - metabolism | Inflammatory Bowel Diseases - metabolism | Esculin - pharmacology | Inflammation - metabolism | Lipid Peroxidation - drug effects | Anti-Inflammatory Agents - therapeutic use | Umbelliferones - therapeutic use | Phytotherapy | Inflammatory Bowel Diseases - prevention & control | Anti-Inflammatory Agents - pharmacology | Picrates - metabolism | Rats | Antioxidants - pharmacology | Inflammation - etiology | Colon - metabolism | Coumarins - therapeutic use | Coumarins - pharmacology | Umbelliferones - pharmacology | Antioxidants - therapeutic use | Colitis - etiology | Animals | Colitis - metabolism | Inflammation - prevention & control | Oxidative Stress - drug effects | Colitis - prevention & control | Plant Extracts - therapeutic use | Peroxidase - metabolism | Antioxidants | Coumarins | Care and treatment | Inflammation | Research | Health aspects | Index Medicus
Journal Article
Drug Development Research, ISSN 0272-4391, 11/2014, Volume 75, Issue 1, pp. S77 - S80
Postmarketing Phase IV Patients with active rheumatoid arthritis ( RA ) frequently show an atherogenic lipid profile, which has been linked with the... 
clinical response | disease activity | anti‐tumor necrosis factor alpha | rheumatoid arthritis | lipid profile | Lipid profile | Disease activity | Clinical response | Rheumatoid arthritis | Anti-tumor necrosis factor alpha | CHEMISTRY, MEDICINAL | THERAPY | anti-tumor necrosis factor alpha | PHARMACOLOGY & PHARMACY | MECHANISMS | TNF-ALPHA | Hydroxychloroquine - therapeutic use | Methotrexate - pharmacology | Certolizumab Pegol | Arthritis, Rheumatoid - blood | Cyclosporine - pharmacology | Cholesterol - blood | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Sulfasalazine - pharmacology | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Polyethylene Glycols - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Antibodies, Monoclonal, Humanized - pharmacology | Immunoglobulin G - pharmacology | Adult | Female | Aspirin - therapeutic use | Antirheumatic Agents - pharmacology | Aspirin - pharmacology | Drug Therapy, Combination | Antirheumatic Agents - therapeutic use | Polyethylene Glycols - pharmacology | Severity of Illness Index | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Antibodies, Monoclonal - pharmacology | Adrenal Cortex Hormones - pharmacology | Immunoglobulin G - therapeutic use | Treatment Outcome | Immunoglobulin Fab Fragments - pharmacology | Cyclosporine - therapeutic use | Lipid Metabolism - drug effects | Triglycerides - blood | Hydroxychloroquine - pharmacology | Aged | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Drugs | Medical research | Rheumatoid factor | Antirheumatic agents | Corticosteroids | Tumor necrosis factor | Atherosclerosis | Medicine, Experimental | Arthritis | Drug therapy | Tumors | Necrosis | Lipids | Metabolism | Cholesterol | Index Medicus
Journal Article
Journal of Ethnopharmacology, ISSN 0378-8741, 08/2016, Volume 190, pp. 354 - 361
L (Wild Mint or Habak) (ML) is used in traditional medicine in treatment of many gastrointestinal disorders. This study aimed to evaluate potential protecting... 
Inflammatory bowel disease | Experimental colitis | Sulphasalazine | Eucalyptol (1,8 cineole) | mentha longifolia | ANTIINFLAMMATORY ACTIVITY | CHEMISTRY, MEDICINAL | 1,8-CINEOLE EUCALYPTOL | ESSENTIAL OIL | PLANT SCIENCES | OCIMUM-BASILICUM | INTEGRATIVE & COMPLEMENTARY MEDICINE | CHEMICAL-COMPOSITION | ASTHMA | PHARMACOLOGY & PHARMACY | TISSUES | STRESS | EXTRACT | Plant Extracts - pharmacology | Tumor Necrosis Factor-alpha - blood | Colon - drug effects | Colitis - pathology | Male | Sulfasalazine - pharmacology | Dose-Response Relationship, Drug | Mentha - chemistry | Monoterpenes - pharmacology | Acetic Acid | Time Factors | Colitis - blood | Interleukin-6 - blood | Colitis - chemically induced | Gastrointestinal Agents - isolation & purification | Malondialdehyde - blood | Anti-Inflammatory Agents - isolation & purification | Cyclohexanols - pharmacology | Phytotherapy | Cytoprotection | Disease Models, Animal | Cyclohexanols - isolation & purification | Monoterpenes - isolation & purification | Anti-Inflammatory Agents - pharmacology | Colon - pathology | Plant Components, Aerial - chemistry | Plant Extracts - isolation & purification | Antioxidants - pharmacology | Biomarkers - blood | Rats, Sprague-Dawley | Colon - metabolism | Gastrointestinal Agents - pharmacology | Animals | Antioxidants - isolation & purification | Colitis - prevention & control | Plants, Medicinal | Glutathione - blood | Peroxidase - metabolism | Drugstores | Colitis | Gastrointestinal diseases | Pharmacy | Index Medicus
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 02/2012, Volume 340, Issue 2, pp. 256 - 265
Journal Article
Radiation Research, ISSN 0033-7587, 10/2016, Volume 186, Issue 4, pp. 385 - 395
The goal of this study was to determine if depletion of glutathione (GSH) and inhibition of thioredoxin (Trx) reductase (TrxR) activity could enhance radiation... 
OXIDATIVE STRESS | INVASION | THERAPY | BIOPHYSICS | PANCREATIC-CANCER | PROSTATE-CANCER | BIOLOGY | SULFASALAZINE | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Buthionine Sulfoximine - pharmacology | Glutathione - metabolism | Neoplastic Stem Cells - drug effects | Humans | Sulfasalazine - pharmacology | Glutathione - biosynthesis | Drug Interactions | Thiocarbamates - pharmacology | Neoplastic Stem Cells - metabolism | Acetylcysteine - analogs & derivatives | Neoplastic Stem Cells - pathology | Female | Thioredoxins - metabolism | Neoplastic Stem Cells - radiation effects | Auranofin - pharmacology | Cell Survival - drug effects | Neoplasm Invasiveness | Radiation-Sensitizing Agents - pharmacology | Cell Survival - radiation effects | Cell Movement - radiation effects | Cell Movement - drug effects | Animals | Breast Neoplasms - pathology | Cell Transformation, Neoplastic | Acetylcysteine - pharmacology | Survival Analysis | Cell Line, Tumor | Mice | Thioredoxin-Disulfide Reductase - antagonists & inhibitors | DNA Damage | Care and treatment | Patient outcomes | Development and progression | Breast cancer | Thioredoxin | Radiotherapy | Health aspects | Glutathione | Index Medicus | Space life sciences | Reductases | Inhibitors | Stem cells | Breast | Inhibition | Human behavior | Metabolism | Cancer
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 07/2017, Volume 450, Issue C, pp. 94 - 104
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 08/2013, Volume 271, Issue 1, pp. 106 - 113
Journal Article
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1422-0067, 09/2011, Volume 12, Issue 9, pp. 6116 - 6134
Journal Article